![Prospective Study of Rituximab in Chemotherapy-Dependent Human Immunodeficiency Virus Associated Multicentric Castleman's Disease: ANRS 117 CastlemaB Trial]()
Prospective Study of Rituximab in Chemotherapy-Dependent Human Immunodeficiency Virus Associated Multicentric Castleman's Disease: ANRS 117 CastlemaB TrialGerard, L.; Berezne, A.; Galicier, L.; Meignin, V.; Obadia, M.; De Castro, N.; Jacomet, C.; Verdon, R.; Madelaine-Chambrin, I.; Boulanger, E.; Chevret, S.; Agbalika, F.; Oksenhendler, E. · Journal of Clinical Oncology · 2007